BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38575743)

  • 1. Effect of low uterine segment involvement on prognosis of early stage endometrial cancer.
    Akdöner A; Kurt S; Yavuz O; Bayram E; Üresin M; Ulukuş EÇ
    J Obstet Gynaecol Res; 2024 Jun; 50(6):991-1001. PubMed ID: 38575743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
    Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
    Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pathologic characteristics of serous carcinoma confined to the endometrium: a multi-institutional study.
    Semaan A; Mert I; Munkarah AR; Bandyopadhyay S; Mahdi HS; Winer IS; Nucci MR; Hussein Y; Quershi F; Hayek K; Tabassum F; Alosh B; Schultz DS; Cote ML; Vijver KK; Morris RT; Oliva E; Ali-Fehmi R
    Int J Gynecol Pathol; 2013 Mar; 32(2):181-7. PubMed ID: 23370657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower uterine segment involvement as a predictor for lymph node spread in endometrial carcinoma.
    Madom LM; Brown AK; Lui F; Moore RG; Granai CO; Disilvestro PA
    Gynecol Oncol; 2007 Oct; 107(1):75-8. PubMed ID: 17629550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion.
    Son J; Chambers LM; Carr C; Michener CM; Yao M; Beavis A; Yen TT; Stone RL; Wethington SL; Fader AN; Burkett WC; Richardson DL; Staley AS; Ahn S; Gehrig PA; Torres D; Dowdy SC; Sullivan MW; Modesitt SC; Watson C; Veade A; Ehrisman J; Havrilesky L; Secord AA; Loreen A; Griffin K; Jackson A; Viswanathan A; Ricci S
    Int J Gynecol Cancer; 2020 Nov; 30(11):1738-1747. PubMed ID: 32771986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
    Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
    Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower uterine segment involvement in lymphovascular space invasion and lymph node metastasis in endometrioid endometrial cancer.
    Cokmez H; Yilmaz A
    Ginekol Pol; 2019; 90(6):314-319. PubMed ID: 31276182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion.
    Simpkins F; Papadia A; Kunos C; Michener C; Frasure H; AbuShahin F; Mariani A; Bakkum-Gamez JN; Landrum L; Moore K; Thomas SG; Windhorn A; Rose PG
    Int J Gynecol Cancer; 2013 Jan; 23(1):98-104. PubMed ID: 23221731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer.
    Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S
    Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastaging of 'negative' pelvic lymph nodes in patients with low- and intermediate-risk endometrioid endometrial cancer who developed non-vaginal recurrences.
    Gill SE; Garzon S; Multinu F; Hokenstad AN; Casarin J; Cappuccio S; McGree ME; Weaver AL; Cliby WA; Keeney GL; Mariani A
    Int J Gynecol Cancer; 2021 Dec; 31(12):1541-1548. PubMed ID: 34706876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK; Zhang HT; Sun YC; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer.
    Matsuo K; Garcia-Sayre J; Medeiros F; Casabar JK; Machida H; Moeini A; Roman LD
    J Surg Oncol; 2015 Nov; 112(6):669-76. PubMed ID: 26391212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma.
    Liang LW; Perez AR; Cangemi NA; Zhou Q; Iasonos A; Abu-Rustum N; Alektiar KM; Makker V
    Int J Gynecol Cancer; 2016 Mar; 26(3):497-504. PubMed ID: 26825840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence patterns and prognostic factors in lymphovascular space invasion-positive endometrioid endometrial cancer surgically confined to the uterus.
    Sahin H; Meydanli MM; Sari ME; Kocaman E; Cuylan ZF; Yalcin I; Coban G; Özen Ö; Sirvan L; Güngör T; Ayhan A
    Taiwan J Obstet Gynecol; 2019 Jan; 58(1):82-89. PubMed ID: 30638487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and recurrence in stage II endometrial cancers in relation to uterine risk stratification after introduction of lymph node resection and omission of postoperative radiotherapy: a Danish Gynecological Cancer Group Study.
    Ørtoft G; Høgdall C; Hansen ES; Dueholm M
    J Gynecol Oncol; 2020 Mar; 31(2):e22. PubMed ID: 31912677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors determining recurrence in early-stage endometrial cancer.
    Misirlioglu S; Guzel AB; Gulec UK; Gumurdulu D; Vardar MA
    Eur J Gynaecol Oncol; 2012; 33(6):610-4. PubMed ID: 23327055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of lymphovascular space invasion in uterine serous carcinoma: what matters more; extent or presence?
    Winer I; Ahmed QF; Mert I; Bandyopadhyay S; Cote M; Munkarah AR; Hussein Y; Al-Wahab Z; Elshaikh MA; Alosh B; Schultz DS; Mahdi H; Nucci MR; Van de Vijver KK; Morris RT; Oliva E; Ali-Fehmi R
    Int J Gynecol Pathol; 2015 Jan; 34(1):47-56. PubMed ID: 25473753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological findings in early-stage endometrial cancer.
    Zehavi S; Schneider D; Bukovsky I; Halperin R
    Eur J Gynaecol Oncol; 2003; 24(1):18-20. PubMed ID: 12691310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome and management of pathological stage I endometrial carcinoma patients with involvement of the lower uterine segment.
    Phelan C; Montag AG; Rotmensch J; Waggoner SE; Yamada SD; Mundt AJ
    Gynecol Oncol; 2001 Dec; 83(3):513-7. PubMed ID: 11733964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucinous adenocarcinoma of the endometrium: case series and review of the literature.
    Jalloul RJ; Elshaikh MA; Ali-Fehmi R; Haley MM; Yoon J; Mahan M; Munkarah AR
    Int J Gynecol Cancer; 2012 Jun; 22(5):812-8. PubMed ID: 22569105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.